BioGenerator

BioGenerator

BioGenerator is a Missouri-based venture development organization providing startup bioscience companies with seed investment.

BioGenerator is an evergreen venture capital investment firm that creates, grows and invests in promising companies and entrepreneurs. The firm is the investment arm of BioSTL and it's work spans the early-stage startup lifecycle of companies within the health and plant sciences. The firm identifies and de-risks commercially promising innovations and services, advises innovators and entrepreneurs, recruits and supports entrepreneurial talent, makes staged investments grounded in rigorous due diligence and offers access to lab space and capital equipment.

Investment

BioGenerator's investments include Healthy Bytes, Covercress, S4, SentiAR, Plastomics, MedAware Solutions, Accuronix Therapeutics, Antegrin Therapeutics, Euclises Pharmaceuticals.

They exited investments Confluence Life Sciences.

Timeline

Funded Companies

Company
Description
Website
Industry
Location

A medical diagnostics company that develops biological assay platform for measuring clinical and point-of-care samples

A company developing and providing products and services in the field of biologics development and functional proteomics

A pharmaceutical manufacturer of products for ophthalmic applications

A company dedicated to drug designs to develop kinase inhibitors for healthcare of human and animals

A company manufacturing and supplying active pharmaceutical ingredients to pharmaceutical companies

Kypha is a St. Louis-based medical diagnostics company.

APT Therapeutics is a St. Louis-based company.

10 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Charlie Bolten

Senior Vice President

Dan Broderick

Vice President

Eric Gulve, PhD

President

Eric Miller, PhD

Senior Investment Analyst

Mark Lewis, PhD

Venture Capital Fellow

Trey Suntrup, PhD

Venture Capital Fellow

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
BioSpace
February 21, 2020
BioSpace
With coaching from BioGenerator's unique Grants-2-Business program, St. Louis bioscience startup VaxNewMo has earned $3 million in federal grant funding to advance the company's development of a next-generation vaccine to combat pneumococcus, the most common cause of bloodstream infections, pneumonia, meningitis, and middle ear infections.

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.